+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer



Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer



Indian Journal of Surgical Oncology 7(1): 67-72



Research on the prognostic value of lymph node ratio (LNR) in gastric cancer (GC) remains limited and controversial results were obtained. In this study, we aimed to evaluate whether LNR was an independent prognostic factor for gastric carcinoma. A retrospective review of a database of gastric cancer patients was performed to determine the effect of the LNR on the overall survival (OS) and the disease-free survival (DFS). Of the total 135 patients with gastric cancer who underwent resection between March 2012 and December 2013, 44 patients with non metastatic gastric cancer were eligible for analysis. Survival curves were estimated using the Kaplan-Meier method. Cox regression analyses, after adjustments for potential confounders, were used to evaluate the relationship between the LNR and survival. According to the cutoff point 0.37 (37 %), the one-year OS rate for LNR ≤ 37 % was significantly better than that for LNR > 37 % (91.3 % and 61.9 %, respectively, P = 0.02). The one-year DFS for LNR ≤ 37 % was significantly better than that for LNR > 37 % (91.3 % and 66.7 %, respectively, P = 0.027). In stratified and multivariate analyses adjusted for age, gender, histology and tumor status, a higher LNR was associated with high pN stage and so associated with worse OS and DFS. Thus, the LNR 37 % as a cutoff point was found not to be an independent factor for predicting the one-year OS or DFS in patients with non-metastatic GC. The LNR is a prognostic factor in GC. However, no single cut-off value was determined as an independent prognostic factor.

(PDF emailed within 0-6 h: $19.90)

Accession: 058635028

Download citation: RISBibTeXText

PMID: 27065685

DOI: 10.1007/s13193-016-0490-8


Related references

P-083 * Prognostic determinants in gastric cancer survival - the importance of metastatic lymph node ratio. Annals of Oncology 26(Suppl 4): Iv23-Iv23, 2015

Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Annals of Coloproctology 29(3): 100-105, 2013

Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World Journal of Gastroenterology 14(27): 4383-4388, 2008

Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World Journal of Gastroenterology 16(16): 2055-2060, 2010

Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer. Oncology Letters 15(6): 8853-8862, 2018

A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification. Asian Journal of Surgery 42(1): 85-92, 2017

Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. European Journal of Surgical Oncology 38(6): 497-502, 2012

Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?. Onkologie 33(3): 101-105, 2010

Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. European Journal of Surgical Oncology 37(6): 488-496, 2011

Prognostic value of metastatic lymph node ratio for gastric cancer patients with less than 15 lymph nodes dissection. Zhonghua Wei Chang Wai Ke Za Zhi 16(2): 151-154, 2014

Prognostic value of metastatic lymph node ratio in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 15(2): 137-140, 2014

Metastatic lymph node ratio as a prognostic factor in gastric cancer. European Journal of Surgical Oncology 31(1): 59-66, 2005

Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. American Journal of Surgery 207(4): 555-565, 2014

Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World Journal of Surgery 26(3): 323-329, 2002

Prognostic value of metastatic lymph node ratio for patients with gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 14(7): 516-519, 2013